| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |